|
⚲
|
| Keyboard |
| Boissel Stephane
✚
|
|
|---|---|
| CIK # | 0001755198 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001755198] | |
| 4 | [0001755198] | |
| 5 | [0001755198] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Sangamo Therapeutics Inc | |
| Boissel Stephane |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Sangamo Therapeutics Inc SGMO
Free Shares Call Options (obligation to sell to Issuer) · derivative
|
2020-07-03 | E | 1 | $0.00 | |
|
Sangamo Therapeutics Inc SGMO
Common Stock
|
2020-06-04 | Disposed to issuer | 14,907 | $11.23 | 167,406 |
|
Sangamo Therapeutics Inc SGMO
Free Shares Put Option (right to sell to Issuer) · derivative
|
2020-06-04 | Option exercise | 1 | $0.00 | |
|
Sangamo Therapeutics Inc SGMO
Common Stock
|
2020-06-04 | Option exercise | 14,907 | ||
|
Sangamo Therapeutics Inc SGMO
Free Shares Call Options (obligation to sell to Issuer) · derivative
|
2020-05-09 | E | 1 | $0.00 | |
|
Sangamo Therapeutics Inc SGMO
Stock Option (Right-to-Buy) · derivative
|
2020-02-25 | Grant | 110,000 | $0.00 | |
|
Sangamo Therapeutics Inc SGMO
Common Stock
|
2020-02-25 | Tax withheld | 2,384 | $6.80 | 16,211 |
|
Sangamo Therapeutics Inc SGMO
Common Stock
|
2020-02-25 | Grant | 55,000 | $0.00 | |
|
Sangamo Therapeutics Inc SGMO
Common Stock
|
2019-08-12 | Disposed to issuer | 11,137 | $11.23 | 125,069 |
|
Sangamo Therapeutics Inc SGMO
Common Stock
|
2019-08-12 | Option exercise | 11,137 | ||
|
Sangamo Therapeutics Inc SGMO
Free Shares Put Option (right to sell to Issuer) · derivative
|
2019-08-12 | Option exercise | 1 | $0.00 | |
|
Sangamo Therapeutics Inc SGMO
Free Shares Call Options (obligation to sell to Issuer) · derivative
|
2019-07-03 | E | 1 | $0.00 | |
|
Sangamo Therapeutics Inc SGMO
Stock Option (Right-to-Buy) · derivative
|
2019-02-25 | Grant | 105,000 | $0.00 | |
|
Sangamo Therapeutics Inc SGMO
Common Stock
|
2019-02-25 | Grant | 17,500 | $0.00 | |
|
Sangamo Therapeutics Inc SGMO
Free Shares Put Options (right to sell to Issuer) · derivative
|
2018-11-27 | Other | 4 | $0.00 | |
|
Sangamo Therapeutics Inc SGMO
Free Shares Call Options (obligation to sell to Issuer) · derivative
|
2018-11-27 | Other | 4 | $0.00 | |
|
Sangamo Therapeutics Inc SGMO
Stock Option (Right to Buy) · derivative
|
2018-11-23 | Grant | 283,523 | $0.00 |